Syngene Extends Bristol Myers Squibb Partnership to 2035

Syngene Extends Bristol Myers Squibb Partnership to 2035

The contract research organisation renewed its strategic collaboration with the pharmaceutical giant for another decade, ensuring continued support for drug discovery and development programmes.